English

Biohit Oyj - Managers' Transactions - Hahtela

Report this content

Person subject to the notification requirement
Name: Jussi Hahtela
Position: Chief Financial Officer


Issuer: Biohit Oyj
LEI: 74370089ATTSNBXJVT29
Notification type: INITIAL NOTIFICATION
Reference number: 9328/4/6
____________________________________________


Transaction date: 2022-01-14
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: I 2021A
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme


Transaction details
(1): Volume: 20000 Unit price: 0 EUR
Aggregated transactions
(1): Volume: 20000 Volume weighted average price: 0 EUR
____________________________________________

Transaction date: 2022-01-14
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: I 2021B
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme


Transaction details
(1): Volume: 20000 Unit price: 0 EUR
Aggregated transactions
(1): Volume: 20000 Volume weighted average price: 0 EUR
____________________________________________

Transaction date: 2022-01-14
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: I 2021C
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme


Transaction details
(1): Volume: 20000 Unit price: 0 EUR
Aggregated transactions
(1): Volume: 20000 Volume weighted average price: 0 EUR
____________________________________________

Transaction date: 2022-01-14
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: I 2021D
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme


Transaction details
(1): Volume: 20000 Unit price: 0 EUR
Aggregated transactions
(1): Volume: 20000 Volume weighted average price: 0 EUR
____________________________________________

Transaction date: 2022-01-14
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: I 2021E
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme


Transaction details
(1): Volume: 20000 Unit price: 0 EUR
Aggregated transactions
(1): Volume: 20000 Volume weighted average price: 0 EUR
____________________________________________

Transaction date: 2022-01-14
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: II 2021A
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme

Transaction details
(1): Volume: 25000 Unit price: 0 EUR
Aggregated transactions
(1): Volume: 25000 Volume weighted average price: 0 EUR
____________________________________________

Transaction date: 2022-01-14
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: II 2021B
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme

Transaction details
(1): Volume: 25000 Unit price: 0 EUR
Aggregated transactions
(1): Volume: 25000 Volume weighted average price: 0 EUR
____________________________________________

Transaction date: 2022-01-14
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: II 2021C
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme

Transaction details
(1): Volume: 25000 Unit price: 0 EUR
Aggregated transactions
(1): Volume: 25000 Volume weighted average price: 0 EUR
____________________________________________

Transaction date: 2022-01-14
Venue not applicable
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
Instrument name: II 2021D
Nature of the transaction: ACCEPTANCE OF A STOCK OPTION
(X) Linked to stock option programme

Transaction details
(1): Volume: 25000 Unit price: 0 EUR
Aggregated transactions
(1): Volume: 25000 Volume weighted average price: 0 EUR

CEO Päivi Siltala, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com

Biohit in brief Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com

Subscribe

Documents & Links